Version 5.4
Mus musculus Protein: Gm129
Summary
InnateDB Protein IDBP-173937.6
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol Gm129
Protein Name predicted gene 129
Synonyms
Species Mus musculus
Ensembl Protein ENSMUSP00000049308
InnateDB Gene IDBG-173935 (Gm129)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 6 experimentally validated interaction(s) in this database.
They are also associated with 1 interaction(s) predicted by orthology.
Experimentally validated
Total 6 [view]
Protein-Protein 6 [view]
Protein-DNA 0
Protein-RNA 0
DNA-DNA 0
RNA-RNA 0
DNA-RNA 0
Predicted by orthology
Total 1 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0001046 core promoter sequence-specific DNA binding
GO:0005515 protein binding
GO:0070888 E-box binding
Biological Process
GO:0006351 transcription, DNA-templated
GO:0032922 circadian regulation of gene expression
GO:0045475 locomotor rhythm
GO:0045892 negative regulation of transcription, DNA-templated
Cellular Component
GO:0005634 nucleus
GO:0016605 PML body
Protein Structure and Domains
PDB ID MGI:2684975
InterPro
PFAM
PRINTS
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt Q3TQ03
PhosphoSite PhosphoSite-
TrEMBL H3BKT8
UniProt Splice Variant
Entrez Gene 229599
UniGene Mm.331218
RefSeq NP_001028474
MGI ID
MGI Symbol Ciart
OMIM
CCDS CCDS50997
HPRD
IMGT
EMBL AC092855 AK156084 AK164001 BC132471 BC138510 CH466620
GenPept AAI32472 AAI38511 BAE33580 BAE37582 EDL38847

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca